3-iodobenzylguanidine has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA | 1 |
| Aburano, T; Bunko, H; Hisada, K | 1 |
1 review(s) available for 3-iodobenzylguanidine and Cholera Infantum
| Article | Year |
|---|---|
[New horizons for in vivo nuclear medicine in 1980s].
Topics: 3-Iodobenzylguanidine; Amphetamines; Biliary Tract Diseases; Brain Diseases; Coronary Disease; Gastrointestinal Diseases; Humans; Imino Acids; Iodobenzenes; Iofetamine; Krypton; Liver Diseases; Lung Diseases; Neoplasms; Radionuclide Imaging; Technetium; Technetium Tc 99m Lidofenin; Thallium; Tomography, Emission-Computed | 1985 |
1 trial(s) available for 3-iodobenzylguanidine and Cholera Infantum
| Article | Year |
|---|---|
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine | 2001 |